This year has seen several eye drop recalls already and yet another one has been added to this list.
While previous recalls have involved over-the-counter eye drops, the latest recall is for prescription bromefenac opthlamic eye drops. These are an NSAID solution that is usually prescribed to treat pain or swelling after cataract surgery.
The FDA issued the recall due to "Failed Impurities/Degradation Specifications" but no specific details were provided as to what the failed specifications are. It is considered a precautionary recall and no adverse events have been linked to the product.
India-based Alembic Pharmaceuticals Limited initiated the recall and the FDA has categorized the recall as a Class II, which means the products have the "potential to cause temporary or medically reversible adverse health consequences." Details regarding the recall may be found here.
